Executive Search Success Story: Building an Executive Team for a Diabetes Technology Company
How JRG Partners ran a confidential, multi-role search for a diabetes technology company expanding its insulin delivery and connected-care portfolio. The strategy equipped the rapidly growing enterprise with the critical leadership required to balance innovation, compliance, and profitability within an FDA-regulated environment.
Engagement Snapshot
| Client | Confidential — Rapidly growing diabetes technology company (name withheld at client’s request) |
| Industry | Medical devices — diabetes technology |
| Geography | Minneapolis, Boston, San Diego, Silicon Valley, Austin, Chicago, Toronto, and key European hubs |
| Engagement | Confidential retained search — multi-role leadership mandate |
| Roles Searched | CEO, VP Product Development, VP Regulatory Affairs, VP Quality Systems, VP Global Operations, VP Commercial Strategy, clinical affairs leadership, diabetes technology innovation leaders |
| Talent Assessed | 500+ senior executives evaluated |
| Timeline | All mission-critical executive roles successfully filled within 12 months |
The Challenge
A rapidly growing diabetes technology company was expanding its portfolio of insulin delivery systems across global markets. It needed an executive team able to balance innovation, compliance, and profitability. Leadership identified several commercial and operational pressures:
- Increasing competition from established diabetes technology manufacturers
- Growing regulatory and quality requirements across global markets
- Demand for faster product development and commercialization cycles
- Complex manufacturing and supply chain management challenges
- Succession concerns within key leadership positions
- A need for executives able to balance innovation, compliance, and profitability
The mandate included confidential recruitment across Chief Executive Officer, VP Product Development, VP Regulatory Affairs, VP Quality Systems, VP Global Operations, VP Commercial Strategy, clinical affairs leadership, and diabetes technology innovation leaders. It needed a partner with deep diabetes-technology search expertise. For organizations evaluating how medical product platforms scale commercial and clinical architectures under tight regulations, a parallel analysis can be reviewed in Diabetes_Insulin_Device_A_Whitelabeled.docx.
Why They Chose JRG Partners
Deep Diabetes-Technology Specialization
Our dedicated practices span diabetes technology, insulin delivery, regulatory affairs, and commercial strategy.
Real Access to Passive Talent
Many of the strongest diabetes-technology leaders are not actively looking. We drew on long-standing relationships and proprietary market intelligence to reach leaders invisible through conventional channels.
Confidential Search Execution
With global expansion at stake, we ran a discreet process that protected continuity and confidence.
Global Reach
The search targeted leaders from diabetes technology, insulin delivery, and continuous glucose monitoring organizations.
Our Corporate Search Strategy
Phase 1 — Leadership Assessment
We worked directly with the board and executive team to map organizational gaps, succession risks, growth objectives, and the competencies the business would need as it scaled. Profiles were built against the company’s long-term strategy rather than legacy job descriptions.
Phase 2 — Market Mapping
Our market map spanned diabetes technology companies, insulin delivery device manufacturers, continuous glucose monitoring organizations, digital health providers, medical device companies, and biotechnology organizations.
Phase 3 — Engagement
Our consultants discreetly engaged leaders with proven records balancing innovation, compliance, and profitability. Only candidates with measurable impact advanced.
Phase 4 — Assessment & Selection
Each finalist went through extensive evaluation covering strategic and functional capability, leadership and team-building, cultural alignment, and long-term retention.
Results Delivered
JRG Partners completed multiple executive placements to effectively build out the core leadership team.
- Strengthened Leadership Team: New leadership successfully strengthened the executive team.
- Accelerated Product Development: Product development timelines accelerated across the portfolio.
- Enhanced Regulatory Performance: Regulatory performance and quality systems compliance improved significantly.
- Expanded Commercial Success: Placed commercial leaders successfully grew the business and expanded market presence.
- Strong Executive Retention: Placed executives stayed beyond the critical transition period and successfully drove long-term strategy.
- Increased Board Confidence: Strategic executive hiring successfully reinforced board and investor confidence.
Key Outcomes
- 500+ senior executive profiles systematically mapped and evaluated across key international medical technology corridors.
- Successfully completed a comprehensive, confidential multi-role leadership mandate within a strict 12-month timeline.
- Recruited high-impact executives across CEO, VP Product Development, VP Regulatory Affairs, VP Quality Systems, VP Global Operations, and VP Commercial Strategy roles.
- Engaged passive talent from leading diabetes technology, insulin delivery, and continuous glucose monitoring organizations.
- Aligned organizational needs with long-term strategy to replace legacy descriptions with future-proof competency profiles.
- Protected continuity and corporate growth metrics during an expansive global transition phase through strict search confidentiality.
- Equipped the Board of Directors with a high-performance management framework primed to manage complex global supply chains and regulatory demands.
Scaling a Diabetes Technology Company?
JRG Partners helps diabetes technology companies recruit leaders who balance innovation and compliance.
Connect with our search team to discuss your mandate.
Connect With Our Diabetes Technology Sourcing Experts